Longevity Pharmaceuticals

Telmisartan

Research / preclinical

Also known as: Micardis

ARB blood pressure med with PPARγ activity — investigational longevity application.

Open in AppAsk AI Advisor

Mechanism

ARB with PPARγ activity. ARB blood pressure med with PPARγ activity — investigational longevity application. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.

Peer-Reviewed Studies (2)

Telmisartan PPARγ Partial Agonism

Hypertension · 2004

Demonstrated unique dual ARB + PPARγ activity.

PubMed PMID 15123577 →

ONTARGET Telmisartan Cardiovascular Outcomes

NEJM · 2008

Telmisartan equivalent to ramipril for cardiovascular events.

PubMed PMID 18378520 →

Related Compounds

Rapamycin

The only molecule shown to extend lifespan in every species tested — yeast to mammals.

Metformin

Most-prescribed diabetes drug, repurposed as the first FDA-approved aging trial.

Acarbose

Lifespan-extending diabetes drug — slows carb absorption, blunts post-meal glucose.

Low-Dose Naltrexone (LDN)

Off-label utility player — autoimmune modulation, pain reduction, HPA-axis support.

SGLT2 Inhibitors (Empagliflozin)

Diabetes drug with off-label longevity interest — cardiac, renal, metabolic benefits.

Doxycycline (low-dose)

MMP modulator at sub-antibiotic dose — connective tissue, periodontal support.